BIOADAPTIVES, INC.
OTC · CIK 0001575142 · Fiscal year end 1231
Latest reported period: Latest published period
Revenue
$5,514
Cost Of Revenue
$1,401
Gross Profit
$4,113
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $5,514 | - | - |
| Cost Of Revenue | $1,401 | - | - |
| Gross Profit | $4,113 | - | - |
| Operating Income | $-198,218 | - | - |
| Net Income | $-111,086 | - | - |
| Eps Diluted | -0.01 | - | - |
| Total Assets | $135,949 | - | - |
| Total Liabilities | $2.3M | - | - |
| Shareholders Equity | $-2.1M | - | - |
| Operating Cash Flow | $-84,839 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | BIOADAPTIVES, INC. | 2026-05-15 | 0001640334-26-000911 |
| 10-K | BIOADAPTIVES, INC. | 2026-04-14 | 0001640334-26-000718 |
| 10-Q | BIOADAPTIVES, INC. | 2025-11-14 | 0001640334-25-002081 |
| 10-Q | BIOADAPTIVES, INC. | 2025-08-14 | 0001640334-25-001493 |